CAS: 672926-33-9 - (αS)-1,4-Dihydro-α-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide

Formule : C₂₀H₂₀N₆O₄S

InChI : InChI=1S/C20H20N6O4S/c1-9(2)14(26-18(28)12-7-5-6-8-13(12)22-20(26)29)16(27)23-19-21-10(3)15(31-19)17-25-24-11(4)30-17/h5-9,14H,1-4H3,(H,22,29)(H,21,23,27)/t14-/m0/s1

Code InChI : InChIKey=OHVKUJISCPKSER-AWEZNQCLSA-N

SMILES : O=C1NC=2C=CC=CC2C(=O)N1C(C(=O)NC3=NC(=C(S3)C4=NN=C(O4)C)C)C(C)C

Synonymes :

• (2S)-2-(2,4-Dioxo-1H-quinazolin-3-yl)-3-methyl-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-2-yl]butanamide
• (αS)-1,4-Dihydro-α-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-3(2H)-quinazolineacetamide
• 3(2H)-Quinazolineacetamide, 1,4-dihydro-α-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-, (αS)-

Kif15-IN-2

CAS : 672926-33-9

Kif15-IN-2 is a peptide that binds to the KIF15 protein. It is an activator of …

• Formule : C₂₀H₂₀N₆O₄S
• Degré de pureté : Min. 95%
• Masse moléculaire : 440.48 g/mol

Kif15-IN-2

CAS : 672926-33-9

Kif15-IN-2 is a kinesin Kif15 inhibitor with potential anticancer activity and can be used in …

• Formule : C₂₀H₂₀N₆O₄S
• Degré de pureté : 98.17%
• Couleur et forme : Solid
• Masse moléculaire : 440.48